Trial
NCT01532960
Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Craig L Slingluff, Jr
Collaborators
—
Condition
Breast Cancer
Intervention
poly-ICLC
Why stopped
Futility for immune responses to the vaccine. Also, a component of study drug was in short supply.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-08